• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Life Sciences | News, Analysis, Insights - HIT Consultant

M&A: New Day Diagnostics to Acquire the Assets of Epigenomics AG

by Fred Pennic 07/31/2023 Leave a Comment

M&A: New Day Diagnostics to Acquire the Assets of Epigenomics AG

What You Should Know:  New Day Diagnostics LLC announced it has entered into an agreement to acquire the assets of Epigenomics AG, a molecular diagnostics company focused on blood testing for the early detection of cancer.Under the terms of the agreement, New Day Diagnostics would acquire substantially all of Epigenomics AG’s assets and intellectual property. The acquisition would expand New Day Diagnostics' portfolio in the cancer diagnostics space and include proprietary biomarker
Read More

NABP, IBM Partner to Build Platform to Protect Drug Supply Chain

by Syed Hamza Sohail 07/27/2023 Leave a Comment

NABP, IBM Partner to Build Digital Platform to Protect Drug Supply Chain

What You Should Know: The National Association of Boards of Pharmacy® (NABP®) and IBM Consulting are pleased to announce their collaboration to build Pulse by NABP™, a new digital platform that is intended to bring visibility to the drug supply chain and help protect patients from counterfeit or substandard prescription medications.Launching later in the summer of 2023, the platform is designed to facilitate manufacturers, wholesalers, pharmacies, and regulators to identify
Read More

ALZpath Secures Funding for Blood-Based Biomarker Testing for Alzheimer’s Disease Detection

by Fred Pennic 07/21/2023 Leave a Comment

ALZpath Secures Funding for Blood-Based Biomarker Testing for Alzheimer's Disease Detection

What You Should Know:  - ALZpath, a developer of blood-based diagnostic biomarker testing for Alzheimer's disease detection receives funding from the Alzheimer’s Drug Discovery Foundation (ADDF)’s Diagnostics Accelerator to accelerate the clinical availability  of ALZpathDx as a laboratory developed test (LDT).  - ALZpathDx is a novel, proprietary assay for blood-based measurement of phosphorylated tau at threonine 217 (pTau217), a highly accurate, diagnostic biomarker for
Read More

SiPhox Health Secures $27M for Lab-Grade Home Health Testing with Silicon Photonics

by Fred Pennic 07/19/2023 Leave a Comment

SiPhox Health Secures $27M for Lab-Grade Home Health Testing with Silicon Photonics

What You Should Know:  - Today, SiPhox Health, a Burlington, MA-based company building the next generation of lab-grade home health testing with silicon photonics raises $27M in funding, including a $10M Seed led by Khosla Ventures and Y Combinator, and a $17M Series A led by Intel Capital. - The SiPhox Home and Health testing systems offer innovative and efficient blood collection solutions for consumers, healthcare systems, pharmaceutical companies, and research teams focusing on
Read More

The Problem With Modern Disinfectants & What The Future of Infection Protection Should Look Like

by Dr. Vikram K. Kanmukhla, VP of Technical Product Management for AvantGuard, Inc. 07/19/2023 Leave a Comment

The Problem With Modern Disinfectants & What The Future of Infection Protection Should Look Like

Keeping surfaces pathogen-free is crucial in preventing the transmission of diseases and infections. Pathogens are microorganisms that can cause illness, and they can easily spread from contaminated surfaces to people who come into contact with those surfaces. This is a major concern in healthcare settings such as hospitals, where pathogens can spread easily and cause infections in vulnerable patients. In addition, pathogen spread can also occur in public places such as schools, workplaces, and
Read More

Eli Lilly Acquires Obesity Drug Maker Versanis for $1.9B

by Fred Pennic 07/14/2023 Leave a Comment

Eli Lilly Acquires Obesity Drug Maker Versanis for $1.9B

What You Should Know:  Eli Lilly announced an agreement to acquire Versanis, a private clinical-stage biopharmaceutical company focused on the development of new medicines for the treatment of cardiometabolic diseases for $1.925B in cash. Versanis' lead asset is bimagrumab, a monoclonal antibody that binds activin type II A and B receptors to block activin and myostatin signaling. Bimagrumab is currently being assessed in the BELIEVE Phase 2b study alone and in combination with
Read More

Causaly Secures $60M to Accelerate AI-Powered Biomedical Research

by Fred Pennic 07/13/2023 Leave a Comment

Causaly Secures $60M to Accelerate AI-Powered Biomedical Research

What You Should Know:  Causaly, the leading AI platform for biomedical research raises $60M in Series B funding led by ICONIQ Growth, with participation from Index Ventures, Marathon Venture Capital, EBRD, Pentech Ventures and Visionaries Club. Strategic individuals also participated in the round, including Alex Gorsky (former Chairman and CEO of Johnson & Johnson) and Olivier Pomel (CEO and Co-Founder of Datadog). The investment brings the total funding raised to $93 million,
Read More

Israel Innovation Authority to Invest $31M to Establish R&D Infrastructure Center for Bio-Chips-Based Bio-Devices

by Fred Pennic 07/12/2023 Leave a Comment

Israel Innovation Authority to Invest $31M to Establish R&D Infrastructure Center for Bio-Chips-Based Bio-Devices

What You Should Know:  The Israel Innovation Authority announced today a NIS 113M ($31M USD) investment for the establishment of a center that will provide research and development (R&D) infrastructure for bio-devices based on bio-chips. The investment is part of the National Bio-Convergence Program.Bio-convergence represents the integration of biology and life sciences with engineering and software technologies. The investment is directed at companies dedicated to developing key
Read More

Why PV Signal Teams Must Leverage RWD & Advanced Cognitive Computing

by Art Brown, Director of Product Marketing, LifeSphere Clinical, ArisGlobal 07/12/2023 Leave a Comment

Why PV Signal Teams Must Leverage RWD & Advanced Cognitive Computing

Signal detection — one of the most critical activities within pharmacovigilance (PV) — is the process of searching for and identifying safety signals from a variety of data sources. PV teams typically monitor safety signals for post-market products by reviewing scientific and medical literature, data obtained from clinical studies, and individual case safety reports (ICSRs).  ICSRs gather data supporting reporting adverse events (AEs), product problems, and customer complaints associated
Read More

Verily & L’Oreal Launches Diverse Skin and Hair Health Registry

by Fred Pennic 07/10/2023 Leave a Comment

Verily & L’Oreal Launches Diverse Skin and Hair Health Registry

What You Should Know:  Today, Verily and L’Oreal announced the launch of a multi-year study, My Skin & Hair Journey, to advance precision skin and hair health. This is part of the two companies' multi-year partnership and research collaboration. The My Skin & Hair Journey registry will enroll thousands of self-identifying U.S. women to develop an unprecedented body of knowledge about perceptions and experiences of skin and hair health, including the role of lifestyle,
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 54
  • Go to page 55
  • Go to page 56
  • Go to page 57
  • Go to page 58
  • Interim pages omitted …
  • Go to page 104
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance

Most-Read

Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

M&A: Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

CVS Rebrands Health Services Segment, Launches Model for Retail Pharmacy Reimbursement

CVS Health Formalizes Tax-Free Split-Off to Carve Out CVS Pharmacy by 2028

SAMHSA and ONC Invest $20M in Behavioral Health IT Initiative

ONC Finalizes HTI-5 Deregulatory Rule to Cut $1.55B in Health IT Compliance and Accelerate FHIR APIs

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Redesign Health Study: 71% of Health Systems Adopt an "Epic-First" AI Purchasing Strategy

Redesign Health Study: 71% of Health Systems Adopt an “Epic-First” AI Purchasing Strategy

iRhythm to Acquire VitalConnect for $287.5M to Build Broad Cardiac Intelligence Platform

M&A: iRhythm to Acquire VitalConnect for $287.5M to Build Broad Cardiac Intelligence Platform

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |